Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum
Aekkachai Tuekprakhon(Centre for Human Genetics), Gavin Screaton(University of Oxford), Neil G. Paterson(Diamond Light Source), Síle A. Johnson(Medawar Building for Pathogen Research), Helen M. E. Duyvesteyn(Centre for Human Genetics), Piyada Supasa(University of Oxford), Ali Amini(University of Oxford), Katie Jeffery, Raksha Das(Centre for Human Genetics), Eleanor Barnes(Oxford Health NHS Foundation Trust), Paul Klenerman(John Radcliffe Hospital), Eloise Phillips(Oxford University Hospitals NHS Trust), Helen M. Ginn(Instruct-ERIC), Aiste Dijokaite-Guraliuc(Centre for Human Genetics), Rungtiwa Nutalai(Centre for Human Genetics), Donal Skelly(Virginia Commonwealth University), Daming Zhou(Centre for Human Genetics), Alexander J. Mentzer(Centre for Human Genetics), Philip Goulder(University of Oxford), John Frater(University of Oxford), Anni Jämsén(Centre for Human Genetics), Muneeswaran Selvaraj(Centre for Human Genetics), Lizzie Stafford, David I. Stuart(Centre for Human Genetics), Jingshan Ren(Centre for Human Genetics), Alexandra Deeks(Centre for Human Genetics), Juthathip Mongkolsapaya(Siriraj Hospital), Lucy Rothwell, Jiandong Huo(Centre for Human Genetics), Lisa Frending(Centre for Human Genetics), Andrew J. Pollard(University of Oxford), Sagida Bibi(University of Oxford), Nigel Temperton(Medway School of Pharmacy), Sandra Adele(Medawar Building for Pathogen Research), Elizabeth E. Fry(Centre for Human Genetics), Susanna Dunachie(University of Oxford), Tom Malone, Hermione J. Webster(University of Oxford), Bede Constantinides(University of Oxford), Derrick W. Crook(Nuffield Orthopaedic Centre), Chang Liu(Centre for Human Genetics), Mark A. Williams(Diamond Light Source), David R. Hall(Diamond Light Source), Siobhan Gardiner(Centre for Human Genetics), Teresa Lambe(University of Oxford), Christopher P. Conlon(Centre for Human Genetics), Thomas Ritter(Oxford University Hospitals NHS Trust)
Cited by 762
Related Papers
Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial
|The Lancet|2020|2.6k
Global distribution and prevalence of hepatitis C virus genotypes
|Hepatology|2014|1.6k
Memory CD8+ T cells vary in differentiation phenotype in different persistent virus infections
|Nature Medicine|2002|1.6k